Bioequivalence Study - Reference Clinical Fexinidazole Tablet Versus Proposed Market Formulation

NCT02571062 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Trypanosomiasis, African

Interventions

DRUG: Fexinidazole

Sponsor

Drugs for Neglected Diseases